Telemonitoring and Protocolized Case Management for Hypertensive Community Dwelling Seniors With Complex Care Needs
TECHNOMED
1 other identifier
interventional
120
1 country
1
Brief Summary
Hypertension affects over 70% of Canadians over the age of 65y. Seniors with hypertension are at high risk for cardiovascular disease and death. Most of this risk is mediated through high blood pressure (BP). However, seniors are also at risk for side effects from BP lowering medication. These can be life threatening and costly. Therefore, BP monitoring is required to ensure BP levels are in the recommended range (neither too high nor low). Home BP monitoring can be used to ensure that BP is in the right range and is recommended for all patients with high BP. Studies in other health care systems show that, to optimally perform home monitoring, the readings should be teletransmitted (electronically sent to the care provider). Additional studies indicate that BP control improves when health care providers (usually pharmacists or nurses) are specifically assigned to review teletransmitted BP readings and, using protocols, make therapeutic adjustments. However, a study needs to be conducted within the Canadian healthcare system to prove that telemonitoring±case management is cost-effective. In addition, proof that seniors consider telemonitoring to be usable and acceptable is required. The investigators will conduct a 200 patient randomized trial in community-dwelling seniors that will compare home BP monitoring alone to telemonitoring plus case management, to comprehensively assess cost-effectiveness, usability, and acceptability. Our partners include TeleMED, a medium sized Canadian technology company with a wealth of experience in medical data management and transmission; Pharmacare, which will provide case-management services. The study will take place in seniors' supportive living residences; by virtue of residing in these institutions, these seniors have complex care needs. This intervention, if effective, cost-effective and safe, can be widely implemented.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable hypertension
Started Sep 2016
Longer than P75 for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 17, 2016
CompletedFirst Posted
Study publicly available on registry
March 29, 2016
CompletedStudy Start
First participant enrolled
September 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 15, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
May 15, 2020
CompletedNovember 4, 2020
November 1, 2020
3.7 years
March 17, 2016
November 2, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Blood Pressure (24-hour Ambulatory Blood Pressure Monitoring, ABPM))
Proportion of patients with overall 24-hour ABPM in the optimal range (110-129 mmHg in patients 65-79y and 110-139 mmHg in patients 80 y or older)
one year
Secondary Outcomes (6)
Blood Pressure
one year
Postural Blood pressure changes
one year
Antihypertensive Medications
one year
Incidence of Treatment-Emergent Adverse Events
one year
Cognition
one year
- +1 more secondary outcomes
Other Outcomes (6)
Cardiovascular Risk Factors
one year
Depression
one year
Frailty
one year
- +3 more other outcomes
Study Arms (2)
Enhanced Usual Care
NO INTERVENTIONParticipants receive a home BP monitor, are taught how to measure home BP and are encouraged to take BP readings to appointments with their providers. In addition, they will be reminded to perform a home BP series each quarter for study outcome purposes, which will encourage self-monitoring. Home BP readings will be teletransmitted for data collection purposes but neither participants nor providers will have access to the these readings. High BP levels that trigger safety alerts to research personnel are the only exception - participants and their primary care providers will be made aware of these.
Telemonitoring and Case Management
ACTIVE COMPARATORHome BP series mean, trends and individual readings will be generated for use by the case manager. Participants in this arm will each be assigned a pharmacist case manager who holds full prescribing privileges and who will: 1. Administer health behaviour modification counselling, teach BP self-monitoring, and monitor medication adherence; 2. Review telemonitored health portal BP summaries and make medication regimen adjustments according to guideline-concordant study protocol; 3. Fax a summary of these adjustments to the participant's primary care provider (to make them aware of treatment changes); and 4. Facilitate communication between participants and providers.
Interventions
Secure, wireless transmission of home blood pressure measurements that are summarized in a secure health portal for healthcare providers use for clinical management decisions, including calculation of mean BP and graphing of temporal trends.
Case managers work collaboratively with patients and physicians to optimize health behaviours, monitor risk factors, implement therapeutic adjustments, encourage adherence, and coordinate follow-up care.
Eligibility Criteria
You may qualify if:
- Documented diagnosis of hypertension.
- Adequate English fluency (both verbal and written).
You may not qualify if:
- Systolic BP level \>220 mmHg or diastolic BP level \>110 mmHg on screening BP measurement (WatchBP \[Microlife Corp., Widnau, Switzerland\]).
- Heart failure
- Severe cognitive impairment, defined as a score of ≥ 5 on the Short Portable Mental Status Questionnaire.
- Severe depression (Patient Health Questionnaire \[PHQ-8\] ≥15).
- Foreshortened life expectancy (\<1y).
- Participation in a concurrent cardiovascular trial.
- Currently receiving case management services for cardiovascular risk factor control.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Albertalead
- Canadian Institutes of Health Research (CIHR)collaborator
- Alberta Innovates Health Solutionscollaborator
Study Sites (1)
Seniors independent living or supportive living residences in greater Edmonton.
Edmonton, Alberta, Canada
Related Publications (1)
Padwal R, McAlister FA, Wood PW, Boulanger P, Fradette M, Klarenbach S, Edwards AL, Holroyd-Leduc JM, Alagiakrishnan K, Rabi D, Majumdar SR. Telemonitoring and Protocolized Case Management for Hypertensive Community-Dwelling Seniors With Diabetes: Protocol of the TECHNOMED Randomized Controlled Trial. JMIR Res Protoc. 2016 Jun 24;5(2):e107. doi: 10.2196/resprot.5775.
PMID: 27343147BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Raj Padwal, MD, Msc
University of Alberta
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, Faculty of Medicine and Dentistry
Study Record Dates
First Submitted
March 17, 2016
First Posted
March 29, 2016
Study Start
September 1, 2016
Primary Completion
May 15, 2020
Study Completion
May 15, 2020
Last Updated
November 4, 2020
Record last verified: 2020-11
Data Sharing
- IPD Sharing
- Will not share